CPD session on hypertension with Professor Markus Schlaich to be hosted in Perth

NPS MedicineWise and its wholly owned subsidiary VentureWise, in collaboration with The George Institute, University of Sydney, Royal Perth Hospital and Curtin University will be hosting a free education session for GPs on hypertension at the University Club of Western Australia on Wednesday 16 May 2018 from 6:30pm.

Entitled Controversies in treating high blood pressure in general practice, the CPD session will include a keynote presentation from renal physician and hypertension specialist, Professor Markus Schlaich, MD, FAHA, FESC, NHMRC Senior Research Fellow. Professor Schlaich is at the forefront of research into hypertension and is the Dobney Chair in Clinical Research at the Royal Perth Hospital and the University of Western Australia.

The session will cover recent research findings in this therapeutic area and the implications to practice, use and interpretation of blood pressure monitoring, including 24-hr monitoring, tailoring hypertension management to patients, and the potential benefits of current clinical trials to patients. It will also include information about a clinical trial (QUARTET) that is being run by the University of Sydney in collaboration with The George Institute, Royal Perth Hospital and Curtin University and how GPs can register to be involved.

This activity has been accredited for 2 (Category 2) points in the RACGP QI & CPD Program for the 2017–2019 triennium (activity number 130393).

GPs interested in attending can register via [email protected] or by calling (03) 9412 5528.

More information

This education session is being held as part of Clinical Trial Assist – a VentureWise initiative powered by NPS MedicineWise and Prospection to increase awareness of clinical trials and build a more streamlined, time efficient and user-friendly model for GPs and practices to identify and refer patients. The George Institute and leading Australian universities are running research projects as part of the pilot. Clinical Trial Assist has been made possible through funding from the MTPConnect Project Fund Program – a dollar-for-dollar matched program investing in big, bold ideas to improve the productivity, competitiveness and innovative capacity of Australia’s medical technology, biotechnology and pharmaceutical sectors.

ENDS

Media enquiries

Jon Abbott 0413 995 189 or email [email protected]

Independent, evidence-based and not-for-profit, NPS MedicineWise enables better decisions about medicines and medical tests. We receive funding from the Australian Government Department of Health.